ポイントオブケアテスト(POCT)のアジア市場

【英語タイトル】Asia Point-of-Care Testing (POCT) Market Insights, Forecast to 2026

QYResearchが出版した調査資料(RG-B23179-AS)・商品コード:RG-B23179-AS
・発行会社(調査会社):QYResearch
・発行日:2020年2月
・ページ数:約110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:アジア
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD7,800 ⇒換算¥998,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

In 2019, the Asia Point-of-Care Testing (POCT) market size was US$ XX million and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX during 2020-2026.
Point-of-Care Testing (POCT) market is segmented by company, region (country), by type, and by application. Players, stakeholders, and other participants in the Asia Point-of-Care Testing (POCT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by type and by application for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Point-of-Care Testing (POCT) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Point-of-Care Testing (POCT) industry.

Segment by Type
 Blood Glucose Testing
 Infectious Diseases Testing
 Cardiac Markers Testing
 Coagulation Testing
 Pregnancy and Fertility Testing
 Others

Segment by Application
 Clinics
 Hospital
 Chronic Disease Detection
 Others

Asia by Region
 China
 Japan
 South Korea
 India
 Australia
 Taiwan
 Indonesia
 Thailand
 Malaysia

By Company
 Roche
 Abbott
 Johnson & Johnson
 Siemens Healthcare
 Danaher
 Ascensia
 Bio-Rad Laboratories
 BioMerieux
 ARKRAY
 Nova Biomedical
 Trividia Health
 Sinocare
 Wondfo
 Yuwell
 Runbio
 KHB
 WuhanEasyDiagnosis Biomedicine
 DAAN GENE
 ACON
 J.H.Bio-Tech
 UPPER Bio-Tech

【レポートの目次】

1 STUDY COVERAGE
1.1 Point-of-Care Testing (POCT) Product Introduction
1.2 Market Segments
1.3 Key Point-of-Care Testing (POCT) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Asia Point-of-Care Testing (POCT) Market Size Growth Rate by Type
1.4.2 Blood Glucose Testing
1.4.3 Infectious Diseases Testing
1.4.4 Cardiac Markers Testing
1.4.5 Coagulation Testing
1.4.6 Pregnancy and Fertility Testing
1.4.7 Others
1.5 Market by Application
1.5.1 Asia Point-of-Care Testing (POCT) Market Size Growth Rate by Application
1.5.2 Clinics
1.5.3 Hospital
1.5.4 Chronic Disease Detection
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Point-of-Care Testing (POCT) Industry Impact
1.6.1 How the Covid-19 is Affecting the Point-of-Care Testing (POCT) Industry
1.6.2 Market Trends and Point-of-Care Testing (POCT) Potential Opportunities in the COVID-19 Landscape
1.6.3 Proposal for Point-of-Care Testing (POCT) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Asia Point-of-Care Testing (POCT) Market Size Estimates and Forecasts
2.1.1 Asia Point-of-Care Testing (POCT) Revenue 2015-2026
2.1.2 Asia Point-of-Care Testing (POCT) Sales 2015-2026
2.2 Point-of-Care Testing (POCT) Market Size by Region: 2020 Versus 2026
3 ASIA POINT-OF-CARE TESTING (POCT) COMPETITOR LANDSCAPE BY PLAYERS
3.1 Asia Top Point-of-Care Testing (POCT) Manufacturers by Sales
3.1.1 Asia Point-of-Care Testing (POCT) Sales by Manufacturer (2015-2020)
3.1.2 Asia Point-of-Care Testing (POCT) Sales Market Share by Manufacturer (2015-2019)
3.2 Asia Top Point-of-Care Testing (POCT) Manufacturers by Revenue
3.2.1 Asia Point-of-Care Testing (POCT) Revenue by Manufacturer (2015-2020)
3.2.2 Asia Point-of-Care Testing (POCT) Revenue Share by Manufacturer (2015-2020)
3.2.3 Asia Point-of-Care Testing (POCT) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Asia Top 10 and Top 5 Companies by Point-of-Care Testing (POCT) Revenue in 2019
3.2.5 Asia Point-of-Care Testing (POCT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Asia Point-of-Care Testing (POCT) Price by Manufacturer (2015-2020)
3.4 Asia Point-of-Care Testing (POCT) Manufacturing Base Distribution, Product Type
3.4.1 Point-of-Care Testing (POCT) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Point-of-Care Testing (POCT) Product Type
3.4.3 Date of International Manufacturers Enter into Point-of-Care Testing (POCT) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Asia Point-of-Care Testing (POCT) Market Size by Type (2015-2020)
4.1.1 Asia Point-of-Care Testing (POCT) Sales by Type (2015-2020)
4.1.2 Asia Point-of-Care Testing (POCT) Revenue by Type (2015-2020)
4.1.3 Point-of-Care Testing (POCT) Average Selling Price (ASP) by Type (2015-2020)
4.2 Asia Point-of-Care Testing (POCT) Market Size Forecast by Type (2021-2026)
4.2.1 Asia Point-of-Care Testing (POCT) Sales Forecast by Type (2021-2026)
4.2.2 Asia Point-of-Care Testing (POCT) Revenue Forecast by Type (2021-2026)
4.2.3 Asia Point-of-Care Testing (POCT) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Asia Point-of-Care Testing (POCT) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Asia Point-of-Care Testing (POCT) Market Size by Application (2015-2020)
5.1.1 Asia Point-of-Care Testing (POCT) Sales by Application (2015-2020)
5.1.2 Asia Point-of-Care Testing (POCT) Revenue by Application (2015-2020)
5.1.3 Point-of-Care Testing (POCT) Price by Application (2015-2020)
5.2 Point-of-Care Testing (POCT) Market Size Forecast by Application (2021-2026)
5.2.1 Asia Point-of-Care Testing (POCT) Sales Forecast by Application (2021-2026)
5.2.2 Asia Point-of-Care Testing (POCT) Revenue Forecast by Application (2021-2026)
5.2.3 Asia Point-of-Care Testing (POCT) Price Forecast by Application (2021-2026)
6 ASIA BY REGION
6.1 Asia Point-of-Care Testing (POCT) Market Facts & Figures by Region, 2015-2020
6.1.1 Asia Point-of-Care Testing (POCT) Sales by Region, 2015-2020
6.1.2 Asia Point-of-Care Testing (POCT) Revenue by Region, 2015-2020
6.2 Asia Point-of-Care Testing (POCT) Market Forecast by Region, 2021-2026
6.2.1 Asia Point-of-Care Testing (POCT) Sales by Region, 2021-2026
6.2.2 Asia Point-of-Care Testing (POCT) Revenue by Region, 2021-2026
6.3 Regions (Country) Overview
6.3.1 China
6.3.2 Japan
6.3.3 South Korea
6.3.4 India
6.3.5 Australia
6.3.6 Taiwan
6.3.7 Indonesia
6.3.8 Thailand
6.3.9 Malaysia
6.3.10 Philippines
6.3.11 Vietnam
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Corporation Information
7.1.2 Roche Description, Business Overview and Total Revenue
7.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.1.4 Roche Point-of-Care Testing (POCT) Products Offered
7.1.5 Roche Recent Development
7.2 Abbott
7.2.1 Abbott Corporation Information
7.2.2 Abbott Description, Business Overview and Total Revenue
7.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.2.4 Abbott Point-of-Care Testing (POCT) Products Offered
7.2.5 Abbott Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporation Information
7.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
7.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Products Offered
7.3.5 Johnson & Johnson Recent Development
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Corporation Information
7.4.2 Siemens Healthcare Description, Business Overview and Total Revenue
7.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Products Offered
7.4.5 Siemens Healthcare Recent Development
7.5 Danaher
7.5.1 Danaher Corporation Information
7.5.2 Danaher Description, Business Overview and Total Revenue
7.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.5.4 Danaher Point-of-Care Testing (POCT) Products Offered
7.5.5 Danaher Recent Development
7.6 Ascensia
7.6.1 Ascensia Corporation Information
7.6.2 Ascensia Description, Business Overview and Total Revenue
7.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.6.4 Ascensia Point-of-Care Testing (POCT) Products Offered
7.6.5 Ascensia Recent Development
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Corporation Information
7.7.2 Bio-Rad Laboratories Description, Business Overview and Total Revenue
7.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Products Offered
7.7.5 Bio-Rad Laboratories Recent Development
7.8 BioMerieux
7.8.1 BioMerieux Corporation Information
7.8.2 BioMerieux Description, Business Overview and Total Revenue
7.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.8.4 BioMerieux Point-of-Care Testing (POCT) Products Offered
7.8.5 BioMerieux Recent Development
7.9 ARKRAY
7.9.1 ARKRAY Corporation Information
7.9.2 ARKRAY Description, Business Overview and Total Revenue
7.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.9.4 ARKRAY Point-of-Care Testing (POCT) Products Offered
7.9.5 ARKRAY Recent Development
7.10 Nova Biomedical
7.10.1 Nova Biomedical Corporation Information
7.10.2 Nova Biomedical Description, Business Overview and Total Revenue
7.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.10.4 Nova Biomedical Point-of-Care Testing (POCT) Products Offered
7.10.5 Nova Biomedical Recent Development
7.11 Trividia Health
7.11.1 Trividia Health Corporation Information
7.11.2 Trividia Health Description, Business Overview and Total Revenue
7.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.11.4 Trividia Health Point-of-Care Testing (POCT) Products Offered
7.11.5 Trividia Health Recent Development
7.12 Sinocare
7.12.1 Sinocare Corporation Information
7.12.2 Sinocare Description, Business Overview and Total Revenue
7.12.3 Sinocare Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.12.4 Sinocare Point-of-Care Testing (POCT) Products Offered
7.12.5 Sinocare Recent Development
7.13 Wondfo
7.13.1 Wondfo Corporation Information
7.13.2 Wondfo Description, Business Overview and Total Revenue
7.13.3 Wondfo Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.13.4 Wondfo Point-of-Care Testing (POCT) Products Offered
7.13.5 Wondfo Recent Development
7.14 Yuwell
7.14.1 Yuwell Corporation Information
7.14.2 Yuwell Description, Business Overview and Total Revenue
7.14.3 Yuwell Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.14.4 Yuwell Point-of-Care Testing (POCT) Products Offered
7.14.5 Yuwell Recent Development
7.15 Runbio
7.15.1 Runbio Corporation Information
7.15.2 Runbio Description, Business Overview and Total Revenue
7.15.3 Runbio Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.15.4 Runbio Point-of-Care Testing (POCT) Products Offered
7.15.5 Runbio Recent Development
7.16 KHB
7.16.1 KHB Corporation Information
7.16.2 KHB Description, Business Overview and Total Revenue
7.16.3 KHB Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.16.4 KHB Point-of-Care Testing (POCT) Products Offered
7.16.5 KHB Recent Development
7.17 WuhanEasyDiagnosis Biomedicine
7.17.1 WuhanEasyDiagnosis Biomedicine Corporation Information
7.17.2 WuhanEasyDiagnosis Biomedicine Description, Business Overview and Total Revenue
7.17.3 WuhanEasyDiagnosis Biomedicine Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.17.4 WuhanEasyDiagnosis Biomedicine Point-of-Care Testing (POCT) Products Offered
7.17.5 WuhanEasyDiagnosis Biomedicine Recent Development
7.18 DAAN GENE
7.18.1 DAAN GENE Corporation Information
7.18.2 DAAN GENE Description, Business Overview and Total Revenue
7.18.3 DAAN GENE Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.18.4 DAAN GENE Point-of-Care Testing (POCT) Products Offered
7.18.5 DAAN GENE Recent Development
7.19 ACON
7.19.1 ACON Corporation Information
7.19.2 ACON Description, Business Overview and Total Revenue
7.19.3 ACON Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.19.4 ACON Point-of-Care Testing (POCT) Products Offered
7.19.5 ACON Recent Development
7.20 J.H.Bio-Tech
7.20.1 J.H.Bio-Tech Corporation Information
7.20.2 J.H.Bio-Tech Description, Business Overview and Total Revenue
7.20.3 J.H.Bio-Tech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.20.4 J.H.Bio-Tech Point-of-Care Testing (POCT) Products Offered
7.20.5 J.H.Bio-Tech Recent Development
7.21 UPPER Bio-Tech
7.21.1 UPPER Bio-Tech Corporation Information
7.21.2 UPPER Bio-Tech Description, Business Overview and Total Revenue
7.21.3 UPPER Bio-Tech Point-of-Care Testing (POCT) Sales, Revenue and Gross Margin (2015-2020)
7.21.4 UPPER Bio-Tech Point-of-Care Testing (POCT) Products Offered
7.21.5 UPPER Bio-Tech Recent Development
8 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
8.1 Market Opportunities and Drivers
8.2 Market Challenges
8.3 Market Risks/Restraints
8.4 Porter’s Five Forces Analysis
8.5 Primary Interviews with Key Point-of-Care Testing (POCT) Players (Opinion Leaders)
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Value Chain Analysis
9.2 Point-of-Care Testing (POCT) Customers
9.3 Sales Channels Analysis
9.3.1 Sales Channels
9.3.2 Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Author Details
11.3 Disclaimer



★調査レポート[ポイントオブケアテスト(POCT)のアジア市場] (コード:RG-B23179-AS)販売に関する免責事項を必ずご確認ください。
★調査レポート[ポイントオブケアテスト(POCT)のアジア市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆